# Efficacy of Cardioviva™ Probiotic Supplement Capsule Formulation

> **NCT01341613** · PHASE2 · COMPLETED · sponsor: **Micropharma Limited** · enrollment: 131 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** Cardioviva™ supplement capsule
- **DIETARY_SUPPLEMENT:** Placebo capsule

## Key facts

- **NCT ID:** NCT01341613
- **Lead sponsor:** Micropharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341613, "Efficacy of Cardioviva™ Probiotic Supplement Capsule Formulation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01341613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*